Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 235,976 | 81,186 | 65,770 | 118,420 | 78,345 |
| Receivables | 886,491 | 809,229 | 754,723 | 776,215 | 756,634 |
| Inventories | 614,500 | 608,973 | 601,433 | 612,454 | 596,359 |
| TOTAL | $1,838,478 | $1,584,692 | $1,510,450 | $1,587,806 | $1,513,294 |
| Non-Current Assets | |||||
| PPE Net | 434,991 | 440,327 | 427,231 | 424,908 | 431,020 |
| Intangibles | 1,183,883 | 1,246,953 | 1,286,633 | 1,329,813 | 1,378,513 |
| Other Non-Current Assets | 142,522 | 150,816 | 140,935 | 158,918 | 138,151 |
| TOTAL | $1,761,396 | $1,838,096 | $1,854,799 | $1,913,639 | $1,947,684 |
| Total Assets | $3,599,874 | $3,422,788 | $3,365,249 | $3,501,445 | $3,460,978 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,202 | 321,175 | 321,790 | 324,213 | 364,692 |
| Accounts payable and accrued liabilities | 800,037 | 730,213 | 694,777 | 757,761 | 684,007 |
| Other current liabilities | 40,598 | 41,515 | 43,503 | 31,755 | 30,181 |
| TOTAL | $862,106 | $1,107,134 | $1,075,824 | $1,129,771 | $1,095,209 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,566,500 | 2,146,403 | 2,153,979 | 2,161,790 | 2,169,607 |
| Other Non-Current Liabilities | 265,460 | 268,591 | 255,023 | 309,057 | 277,816 |
| TOTAL | $2,847,723 | $2,428,187 | $2,421,425 | $2,481,186 | $2,459,336 |
| Total Liabilities | $3,709,829 | $3,535,321 | $3,497,249 | $3,610,957 | $3,554,545 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 314,363 | 314,079 | 313,420 | 309,966 | 309,844 |
| Common Shares | 3,143 | 3,140 | 3,134 | 3,099 | 3,098 |
| Retained earnings | -570,081 | -572,450 | -594,867 | -607,062 | -575,981 |
| Other shareholders' equity | -106,380 | -97,846 | -86,073 | -65,755 | -73,917 |
| TOTAL | $-109,955 | $-112,533 | $-132,000 | $-109,512 | $-93,567 |
| Total Liabilities And Equity | $3,599,874 | $3,422,788 | $3,365,249 | $3,501,445 | $3,460,978 |